Long-term flecainide therapy in type 3 long QT syndrome

ConclusionsThese data suggest that long-term flecainide therapy is relatively safe and effective among LQT3 patients who carry the D1790GSCN5A mutation.
Source: Europace - Category: Cardiology Source Type: research